TAM
SUPN icon

THB Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

THB Asset Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-31,442
Closed -$745K – 183
2019
Q4 		$745K Buy
31,442
+4,728
+18% +$115K 0.14% 114
2019
Q3 		$734K Sell
26,714
-612
-2% -$18.1K 0.14% 119
2019
Q2 		$904K Hold
27,326
– – 0.14% 112
2019
Q1 		$957K Buy
27,326
+122
+0.4% +$4.54K 0.14% 108
2018
Q4 		$903K Hold
27,204
– – 0.13% 104
2018
Q3 		$1.37M Sell
27,204
-3,206
-11% -$158K 0.17% 103
2018
Q2 		$1.82M Buy
30,410
+854
+3% +$44.2K 0.22% 100
2018
Q1 		$1.35M Buy
29,556
+1,000
+4% +$41.7K 0.18% 104
2017
Q4 		$1.14M Buy
28,556
+2,305
+9% +$91.1K 0.15% 107
2017
Q3 		$1.05M Sell
26,251
-1,227
-4% -$53.1K 0.14% 105
2017
Q2 		$1.18M Sell
27,478
-650
-2% -$23.1K 0.15% 103
2017
Q1 		$880K Hold
28,128
– – 0.11% 125
2016
Q4 		$710K Hold
28,128
– – 0.09% 141
2016
Q3 		$695K Sell
28,128
-6,060
-18% -$137K 0.1% 133
2016
Q2 		$696K Sell
34,188
-24,400
-42% -$433K 0.09% 137
2016
Q1 		$893K Sell
58,588
-13,342
-19% -$174K 0.1% 159
2015
Q4 		$966K Sell
71,930
-210,551
-75% -$3.26M 0.1% 167
2015
Q3 		$3.96M Buy
+282,481
New +$5.25M 0.39% 100

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

THB Asset Management's SUPN Position: Q1 2020 in Review

THB Asset Management sold out of Supernus Pharmaceuticals (SUPN) in Q1 2020, closing a stake of 31,442 shares — an estimated $745K sold.

THB Asset Management first reported a position in SUPN in Q3 2015 and held it in 18 quarters. The position peaked at $3.96M in Q3 2015. 208 funds tracked by Wall St. Rank hold SUPN as of Q1 2020.

  • THB Asset Management reported no remaining Supernus Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • THB Asset Management sold 31,442 Supernus Pharmaceuticals shares in Q1 2020, an estimated $745K.
  • THB Asset Management first reported a position in Supernus Pharmaceuticals in Q3 2015 and held it in 18 quarters.
  • THB Asset Management's Supernus Pharmaceuticals position peaked at $3.96M in Q3 2015.
  • 208 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2020.

Based on THB Asset Management's 13F filing for Q1 2020, filed 6 May 2020.